Results 61 to 70 of about 64,665 (70)

CK-666 and CK-869 differentially inhibit Arp2/3 iso-complexes

EMBO Reports
Michael Way, Angika Basant, Luyan Cao
exaly  

Linifanib (ABT-869) enhances radiosensitivity of head and neck squamous cell carcinoma cells

Oral Oncology, 2013
, Saïed Mirshahidi, Daila S Gridley
exaly  

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft

Journal of Hepatology, 2008
Jianbiao Zhou, Zhigang Xie, Daniel H Albert   +2 more
exaly  

Linifanib (ABT-869), enhances cytotoxicity with poly (ADP-ribose) polymerase inhibitor, veliparib (ABT-888), in head and neck carcinoma cells

Oral Oncology, 2014
, Penelope Duerksen-Hughes, Saïed Mirshahidi   +2 more
exaly  

Synthesis of a Multiple Target Receptor Tyrosine Kinase Inhibitors ABT-869

Chinese Journal of Organic Chemistry, 2014
exaly  

Road to ABT‐869: A Multitargeted Receptor Tyrosine Kinase Inhibitor

2009
Daniel H Albert
exaly  

Carcinoma Of The Lip:A Series Of 869 Patients

Acta Oto-Laryngologica, 1973
Karsten Jørgensen
exaly  

Frequency-based electric fingerprint and thermal properties of the NWA 869 chondrite

Journal of African Earth Sciences
Bassem S Nabawy
exaly  

Effect of the New H1 -Antagonist ReN1869 on Capsaicin-induced Hyperalgesia in Human Skin

Arzneimittelforschung, 2004
exaly  

Identification of RIPK1 as a novel target for angiogenesis regulation based on ABT-869 conjugated photoaffinity probes

Bioorganic Chemistry
exaly